Ohori M - Search Results

1

Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.

Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, Wheeler M, Spitler J, Rowley DR. Ayala G, et al. Among authors: ohori m. Clin Cancer Res. 2003 Oct 15;9(13):4792-801. Clin Cancer Res. 2003. PMID: 14581350

2

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

Kattan MW, Shariat SF, Andrews B, Zhu K, Canto E, Matsumoto K, Muramoto M, Scardino PT, Ohori M, Wheeler TM, Slawin KM. Kattan MW, et al. Among authors: ohori m. J Clin Oncol. 2003 Oct 1;21(19):3573-9. doi: 10.1200/JCO.2003.12.037. Epub 2003 Aug 11. J Clin Oncol. 2003. PMID: 12913106 Clinical Trial.

3

Expression of neutral amino acid transporter ASCT2 in human prostate.

Li R, Younes M, Frolov A, Wheeler TM, Scardino P, Ohori M, Ayala G. Li R, et al. Among authors: ohori m. Anticancer Res. 2003 Jul-Aug;23(4):3413-8. Anticancer Res. 2003. PMID: 12926082

4

High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.

Ayala G, Thompson T, Yang G, Frolov A, Li R, Scardino P, Ohori M, Wheeler T, Harper W. Ayala G, et al. Among authors: ohori m. Clin Cancer Res. 2004 Oct 1;10(19):6572-8. doi: 10.1158/1078-0432.CCR-04-0477. Clin Cancer Res. 2004. PMID: 15475446

5

Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.

Ohori M, Abbas F, Wheeler TM, Kattan MW, Scardino PT, Lerner SP. Ohori M, et al. J Urol. 1999 Feb;161(2):500-4. J Urol. 1999. PMID: 9915435

6

Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy.

Herman CM, Kattan MW, Ohori M, Scardino PT, Wheeler TM. Herman CM, et al. Among authors: ohori m. Am J Surg Pathol. 2001 May;25(5):657-60. doi: 10.1097/00000478-200105000-00014. Am J Surg Pathol. 2001. PMID: 11342779

7

The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations.

Ohori M, Wheeler TM, Scardino PT. Ohori M, et al. Cancer. 1994 Jul 1;74(1):104-14. doi: 10.1002/1097-0142(19940701)74:1<104::aid-cncr2820740119>3.0.co;2-5. Cancer. 1994. PMID: 7516262

8

[The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].

Koh H, Maru N, Muramoto M, Wheeler TM, Scardino PT, Ohori M. Koh H, et al. Among authors: ohori m. Nihon Hinyokika Gakkai Zasshi. 2002 Jul;93(5):595-601. doi: 10.5980/jpnjurol1989.93.595. Nihon Hinyokika Gakkai Zasshi. 2002. PMID: 12174634 Free article. Japanese.

9

Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?

Ohori M, Kattan MW, Utsunomiya T, Suyama K, Scardino PT, Wheeler TM. Ohori M, et al. J Urol. 2003 Mar;169(3):964-8. doi: 10.1097/01.ju.0000049963.28489.ab. J Urol. 2003. PMID: 12576823

10

Radical prostatectomy for carcinoma of the prostate.

Ohori M, Kattan M, Scardino PT, Wheeler TM. Ohori M, et al. Mod Pathol. 2004 Mar;17(3):349-59. doi: 10.1038/modpathol.3800056. Mod Pathol. 2004. PMID: 14765206 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters